Press
-
Featured innovator: Samson Phan
SRI senior research engineer is leading exciting advancements in space robotics
-
Expanding cancer immunotherapy by exploiting recall immunity – a new co-therapy option for checkpoint inhibitor
SRI International has developed a novel immunotherapy that is capable of delivering previously encountered antigenic peptides specifically to cancer cells and facilitating their presentation through the MHC class I pathway.
-
75 Years of Innovation: Handwriting recognition
The ability to verify handwritten signatures in real-time
-
75 Years of Innovation: Banking Automation ERMA
A system to provide automated handling of personal checking accounts
-
Invent, Apply, Transition: Making moments of inspiration come to life
The deft execution of this three-pronged business model is at the foundation of the nonprofit’s world-changing technological advancements
-
75 Years of Innovation: Color television
The second NTSC standard, chosen in 1953, was still used until 2000. This standard was chosen for its compatibility with existing black and white sets
-
Immunology is coming to the rescue
SRI scientist explores how to tame and leverage the human immune system to prevent allergies and fight disease
-
75 Years of Innovation: Synthetic polymer, Zylon
A plastic that overtook Kevlar in the 1980s as the world’s strongest polymer
-
SRI introduces DiaCyt™ CNS drug-delivery platform at 2021 JP Morgan Conference
Novel peptide-based technology delivers molecular cargo through the blood brain barrier, enabling CNS drug discovery and therapeutic delivery
-
Featured innovator: Thomas Low
The director of SRI International’s Robotics Laboratory has built a career filled with breakthroughs and world-firsts
-
75 Years of Innovation: Eyetracker
How SRI opened the world’s eyes to the power of eye-tracking
-
Leveraging state-of-the-art encryption technology with DARPA Brandeis PRIME
Encryption technology allows organizations to safeguard their private information